Page last updated: 2024-10-21

xanthine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

xanthine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

7H-xanthine : An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-7 is protonated.
9H-xanthine : An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-9 is protonated.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hata, Y1
Yamaji, Y1
Shiotani, T1
Fujita, J1
Kamano, H1
Ikeda, K1
Takahara, J1
Irino, S1

Other Studies

1 other study available for xanthine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Induction of erythroid differentiation of K562 cells by 4-carbamoylimidazolium 5-olate (SM-108).
    Biochemical pharmacology, 1991, Nov-27, Volume: 42, Issue:12

    Topics: Cell Differentiation; Cell Line; Erythrocytes; Guanosine Triphosphate; Humans; Imidazoles; IMP Dehyd

1991